Latest Clinical Studies for SCI in Japan

MItowebDr. Masatoshi Ito, Executive Director of the Japan SCI Foundation recently gave an update of the clinical trial progress in Japan at Working 2 Walk 2014 hosted by Unite 2 Fight Paralysis.

Since it was founded in 1996, JSCF’s fundamental principle is to reform inadequate Japanese medical attention toward SCI in order to establish a higher level of multidisciplinary SCI care. Today SCI population in Japan is over 100,000, mostly from motor vehicle accidents. Current SCI clinical studies in Japan include testing the effects of diverse cells such as mesenchymal stem cells (Sapporo Medical University), olfactory ensheathing glial cells (Osaka University) and bone marrow stromal cells (Kansai Medical University), demonstrating some functional recovery which still may require additional follow ups. Also, I am excited to present the world’s first clinical study using induced pluripotent stem cells to be launched in Japan in 2017.

Without your valuable support of Unite 2 Fight Paralysis volunteers and your generous donations directed to the Working 2 Walk Video Library, the annual symposium video presentations could not be made possible for the paralysis community. Thank you for your generous support in supplying this educational material for research and advocacy.

This entry was posted in Regenerative Medicine, Spinal Research, Unite 2 Fight Paralysis, Working 2 Walk Science & Advocacy Symposium and tagged , , . Bookmark the permalink.